EN3220
Methamphetamines (Meth) cause a wide array of problems with its users, a lot of which are permanent. Meth’s affects range from neurological issues, alertness, paranoia, and aggression. It also leads to psychological and physical disorders. Because Meth is a stimulant, it can cause the user to be up for days and even weeks at a time causing stress to the body and can result in over exerting oneself and inevitably something will give. Personal problems from users will be talked about, as well as scientific studies on the Meth epidemic. Meth was originally used for medical purposes; it was used to help treat narcolepsy (wanting to sleep), obesity (being overweight), and Attention Deficit Disorder (not being able to stay focused) also known as ADD. Meth is such a preferred drug because of how the effects work, the user will get a long lasting high from a small amount as well as receive more energy and alertness without having to eat and sleep. The user will also experience hyperactivity, irritability, malnutrition, shortness of breath and thoughts of suicide do to depression when they start coming down from the high. Excessive use of Meth will cause lung and kidney disorders, as well as damage to the liver and brain which can cause issues of psychological problems and even having a stroke. During the time of the user trying to get off of the drug they will start to experience increased depression, being sad about everything, and have a huge craving for more. Meth is a very controlling drug and can so many effects on the users brain that they will lose themselves to meth and allow it to take over their life. One of the worst parts of meth is that the family and friends of the user suffer from its affects mentally as the user suffers physically. The innocence of children is the worst part of meth abuse. As the parent smokes meth, the children in the house are subject to the second hand smoke and inevitably
Citations: Coffin, P., Santos, G., Das, M., Santos, D. M., Huffaker, S., Matheson, T., & ... Colfax, G. N. (2013). Aripiprazole for the treatment of methamphetamine dependence: a randomized, double-blind, placebo-controlled trial. Addiction, 108(4), 751-761. doi:10.1111/add.12073 Cunningham, S., & Finlay, K. (2013). PARENTAL SUBSTANCE USE AND FOSTER CARE: EVIDENCE FROM TWO METHAMPHETAMINE SUPPLY SHOCKS. Economic Inquiry, 51(1), 764-782. doi:10.1111/j.1465-7295.2012.00481.x Huabing, L., Qiong, L., Enhua, X., Qiuyun, L., Zhong, H., & Xilong, M. (2014). Methamphetamine Enhances the Development of Schizophrenia in First-Degree Relatives of Patients With Schizophrenia. Canadian Journal of Psychiatry, 59(2), 107-113 Loftis, J. M., Wilhelm, C. J., Vandenbark, A. A., & Huckans, M. (2013). Partial MHC/Neuroantigen Peptide Constructs: A Potential Neuroimmune-Based Treatment for Methamphetamine Addiction. Plos ONE, 8(2), 1-8. doi:10.1371/journal.pone.0056306 Tolliver, B. K., Price, K. L., Baker, N. L., LaRowe, S. D., Simpson, A. N., McRae-Clark, A. L., & ... Brady, K. T. (2012). Impaired Cognitive Performance in Subjects with Methamphetamine Dependence during Exposure to Neutral versus Methamphetamine-Related Cues. American Journal of Drug & Alcohol Abuse, 38(3), 251-259. doi:10.3109/00952990.2011.644000